It’s a sign of the times that this year’s American Diabetes Association (ADA) Scientific Sessions meeting in New Orleans ...

Twenty-six years of chasing New York City sex crimes as the face of “Law & Order: Special Victims Unit” has prepared ...

For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first ...

The new expansion covers all patients 6 and older, regardless of their inhibitor status. The new nod also opens up the ...

In the persistence and adherence analysis, which looked at 28 studies including 267,542 patients, Amgen found that 69% of ...

The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative which could ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...

The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. | The drumbeat of news regarding ...

With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its ...

Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...